Biotech and Big Pharma Dominate this Week's Insider Buys

Odonate ODT's Chairman and CEO Kevin Tang has made open market purchases of more than $36 million in so far this June, including $10 million on the spot secondary at the highest price his paid all…


Carnival gets a nod from Barron's Roundtable

This weekend Barron's roundtable member, Brian Rogers, plugged our largest holding, CCL.  If it gets the bounce we expect Monday, we'll probably lighten up a little as we have an outsized position.…